Navigation Links
Influenza Vaccines Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Date:10/17/2011

fluenza Vaccines – Regulatory Filed Products, 2011 42

Table 18: Influenza Vaccines – Phase III Pipeline, 2011 43

Table 19: Influenza Vaccines – Phase II Pipeline, 2011 43

Table 20: Influenza Vaccines – Phase I Pipeline, 2011 44

Table 21: Influenza Vaccines – Pre-Clinical Pipeline, 2011 45

Table 22: Influenza Vaccines – Discovery Pipeline, 2011 46

Table 23: Influenza Vaccines – Most Promising Drugs Under Clinical Development, 2011 49

Table 24: Influenza Vaccines – Clinical Trials by Country, 2011 53

Table 25: Influenza Vaccines – Clinical Trials by Phase, 2011 54

Table 26: Influenza Vaccines – Clinical Trials by Status, 2011 55

Table 27: Influenza Vaccines – Overall Sponsors, 2011 56

Table 28: Influenza Vaccines – Prominent Sponsors, 2011 57

Table 29: Influenza Vaccines – Top Companies Participating in Clinical Trials, 2011 58

Table 30: Astrazeneca - Influenza Pipeline Products, 2011 63

Table 31: GlaxoSmithKline - Influenza Pipeline Products, 2011 65

Table 32: Novartis AG - Influenza Pipeline Products, 2011 66

Table 33: Baxter International - Influenza Pipeline Products, 2011 67

Table 34: Influenza Vaccines: Licensing and Partnership Deals, 2011 68

List of Figures

Figure 1: Comparison of Seasonal and Pandemic Influenza 7

Figure 2: Comparison of Influenza A, B and C 9

Figure 3: Comparison of Influenza and the Common Cold 11

Figure 4: Influenza Virus Testing Methods 12

Figure 5: Clinical Algorithm for Consideration in the Assessment of Persons with Mild or Uncomplicated Influenza Illness 13

Figure 6: Influenza Vaccines Market, Global, Revenue ($m), 2005–2010 15

Figure 7: Influenza Vaccines Market, Global, Forecast ($m), 2011–2018 16

Figure 8: Influenza Vaccines Market, The US, Revenue ($m), 2005
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. GSK Begins Shipments of Fluarix(R) and FluLaval(R) to U.S. Customers for 2008-2009 Influenza Season
2. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
3. Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season
4. Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate
5. Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
6. Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program
7. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
8. Peramivir Phase 2 Data for the Treatment of Outpatient Influenza to be Presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
9. BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
10. A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks
11. Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015 WuXi PharmaTech (Cayman) Inc. ... capability and technology platform company serving the global ... that an Investigational New Drug (IND) application for ... arthritis has been accepted for review by the ... In September 2012, MedImmune, the global biologics ...
(Date:3/26/2015)... Bioscience, Inc. (NASDAQ: ROKA ), a molecular ... for the detection of foodborne pathogens, today reported ... full year ended December 31, 2014. ... ended December 31, 2014 was $1.4 million compared ... and $1.5 million for the third quarter of ...
(Date:3/26/2015)... The Market Element LLC, a leading ... with Designing Gig LLC to provide website design, development, ... “Forging this alliance with Designing Gig represents a pivotal ... a comprehensive, end-to-end, digital solution for our clients, which ... Chuck Miller, president of The Market Element. “For small ...
(Date:3/26/2015)... 2015 Neogen Corporation (NASDAQ: NEOG ) ... quarter of fiscal 2015, which ended Feb. 28, increased ... $6,575,000. Earnings per share in the current quarter were ... net income increased 17% over prior year to $24,142,000, ... per share, for the same period a year ago. ...
Breaking Biology Technology:Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 2Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 4Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 5Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 6Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 7The Market Element LLC and Designing Gig LLC Form Strategic Alliance 2Neogen reports 13% increase in net income 2Neogen reports 13% increase in net income 3Neogen reports 13% increase in net income 4Neogen reports 13% increase in net income 5Neogen reports 13% increase in net income 6Neogen reports 13% increase in net income 7Neogen reports 13% increase in net income 8
... Today sees the announcement of full details of how an ... at the forefront of research into ,wonder material, graphene. Also ... and research technology. 200 times stronger than ... strongest and thinnest material ever measured, and also the world,s ...
... PARK, Calif., Feb. 2, 2012 Auxogyn, Inc., a privately-held ... close of the final tranche of its Series A financing, ... was placed in May 2010, and investors in the round ... Serono Ventures. "Over the course of the last ...
... Feb. 2, 2012   Reportlinker.com announces that a ... its catalogue: U.S. Tissue ... The scope of this research ... companies in the wound care and surgery ...
Cached Biology Technology:New investment aims to establish the UK as a global graphene research hub 2New investment aims to establish the UK as a global graphene research hub 3Auxogyn Completes $20 Million In Series A Funding 2Auxogyn Completes $20 Million In Series A Funding 3U.S. Tissue Engineering Markets 2U.S. Tissue Engineering Markets 3
(Date:3/20/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4stcg3/india_sensors ... "India Sensors Market Forecast and Opportunities 2020" ... market is projected to grow at a CAGR ... automotive, industrial and healthcare sectors are the key ... addition, adoption of MEMS technology in sensors is ...
(Date:3/20/2015)... 19, 2015 Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ... - Global Strategic Business Report" report to their offering. ... Biometrics in US$ Thousands. The report provides separate comprehensive analytics ... Japan , Europe , ... Latin America . Annual estimates ...
(Date:3/17/2015)... MedNet Solutions , a global ... management systems, is pleased to announce that company ... in Clinical Trials Southeast conference – March 24-25 ... forum for MedNet to showcase iMedNet , ... eClinical technology platform. We strongly encourage ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
... Arsenic from treated lumber used in decks, utility poles ... decades to come, possibly threatening groundwater, according to two ... University of Miami, the University of Florida and Florida ... or CCA-treated wood, from a real deck as well ...
... , The recent discovery of a 90-million-year-old dinosaur ... carnivorous theropods that includes Velociraptor and is closely ... thought. Rather than originating during the Cretaceous, dromaeosaurs ... possibly as far back as 180 million years ...
... weapons used by our immune system to absorb and ... defence mechanism and even multiply within the macrophages. Cell ... a strategy in a recently publication in the journal ... findings reveal that the pathogens escape the 'stomach' of ...
Cached Biology News:Researchers: Treated wood poses long-term threat 2Researchers: Treated wood poses long-term threat 3Newly discovered birdlike dinosaur is oldest raptor ever found in South America 2Newly discovered birdlike dinosaur is oldest raptor ever found in South America 3Newly discovered birdlike dinosaur is oldest raptor ever found in South America 4Dangerous tricksters: Some bacterie use immune cells to reproduce 2Dangerous tricksters: Some bacterie use immune cells to reproduce 3
... intended for laboratory research use only. ... buffered formalin and embedded in paraffin. ... certified pathologists. Tissue cores were removed ... a new recipient paraffin block, in an ...
... kit contains all the reagents required for ... c reductase activity in cell and tissue ... (ER)]. It has been tested on samples ... kidney, brain, spleen, and heart muscle from ...
... Cell Sets Sets of pET host ... The most common method for transformation ... is to use chemically competent cells. Although ... laboratory, greater efficiency, reproducibility and convenience are ...
The Saturn 2200 answers your GC/MS questions with the CP-3800 GC and the 2000 Series Ion Trap MS! These components create a platform for the worlds most versatile GC and flexible MS. Both deliver une...
Biology Products: